Home | Mysite

The Crowley Center

for Regenerative

Biotherapeutics LLC

Crowley-Center-for-Regenerative-Biotherapeutics-1024x576 (1).jpg

Nano-D tags use a revolutionary advanced optical encryption technology system that allows the digital world to be connected to both the physical & digital worlds using a Billion Bit Key Based Encryption System embedded in an ultra-thin metal or polymer device that connects lender & borrowers and patients & medical professionals via an unhackable nano-pseudo holographic Matrix. Incredible but True!

Our Mission

The Crowley Center is a private, family owned, U.S.-based regenerative biotherapeutics, medical and /aesthetics investment and advanced technology commercialization company focusing upon the development of Umbilical Cord Wharton’s Jelly-derived allogenic off-the-shelf stem cell and exosome therapies and biomaterial-based regenerative therapeutics products

Investment Strategy

“The Crowley Center’s unique investment and commercialization strategy leverages a diversified portfolio of regenerative medical and biotherapeutic technologies all derived from a single donated source material — the ethically sourced post-partum Wharton’s Jelly derived from umbilical cords of healthy births. As one of America’s leading venture building firms, our Company has pioneered the use of off-the-shelf Wharton’s Jelly-derived stem cells and exosomes, and as one of the world’s leading manufacturing innovators in Wharton’s Jelly biomaterial product development, The Crowley Center’s business model is to generate commercial revenue from both cellular and regenerative biotherapeutics, including technologies that combine cellular, exosome and regenerative biotherapeutics.

Mobility

The Crowley Center is fortunate to have world-leading advisors and experts across diverse scientific and medical fields who provide unique insights and breakthrough discoveries. We are excited to integrate this expertise across our company, to connect technology innovation with better health outcomes for patients, including Regenerelle's WJ-MSC stem cell & exosome medical grade products and Resiliélle’s topical exosome-based cosmetics product for skin renewal and hair regrowth designed for MedSpas, Dermatologists and Plastic Surgeons, “A strong scientific, cosmetics-customer and patient-centered mindset across all stages of manufacturing and new product development will enable innovation in the application of cosmeceuticals all the way to groundbreaking translational medicine later saving and improving lives, but also addresses the need for skin regeneration/rejuvenation or hair regrowth hair when used with adjunct therapies such as microneedling, laser treatments, or other related skin and scalp treatments.”